Curon Medical Stretta System

Device for treatment of gastroesophageal reflux disease (GERD) receives FDA market go-ahead. The procedure applies controlled radiofrequency energy through a flexible catheter to the lower esophageal sphincter to improve the barrier function of the valve and stop reflux. Bard's endoscopic suturing device for GERD received 510(k) clearance on March 20 (1"The Gray Sheet" April 10, p. 11)

More from Archive

More from Medtech Insight